Bone Health

Immunology

Hematology

Respiratory

Dermatology

Diabetes

Gastroenterology

Neurology

Oncology

Ophthalmology

Rare Disease

Rheumatology

News

Media

All Videos

Insights

Interviews

Peer Exchange

Podcasts

Compendia

Conferences

Conference Coverage

Conference Listing

CME/CE

Resources

Authors

Biosimilar Resources

Interactive Tools

WHEN CHOICE ARRIVES: Competition & Consequences

Subscribe

E-News

Print Subscription

BIOSIMILAR APPROVALS

Articles

If biosimilars are introduced to Spain, they will most likely save money in the pharmacological budget, according to a budget impact analysis model.

Spain Could Save Millions With Greater Bevacizumab Biosimilar Adoption

Alvotech and Advanz Pharma extend their partnership to commercialize 5 biosimilar candidates across Europe.

Alvotech, Advanz Pharma Extend Partnership for Biosimilars in Europe

Videos

Here are the top 5 biosimilar articles for the week of May 29, 2023.

The Top 5 Biosimilar Articles for the Week of May 29

The Mark Cuban Cost Plus Drug Company, an online pharmacy dedicated to increasing access to lower-cost prescriptions, is partnering with Coherus Biosciences to distribute Yusimry, a biosimilar referencing Humira. It’s the first time the pharmacy has added a biosimilar to its list of drugs.

Mark Cuban’s Online Pharmacy Partners With Coherus Biosciences for Humira Biosimilar

About

Contact

Advisory Board

Do Not Sell My Information

Terms & Conditions

Privacy Policy

Center for Biosimilars®

Facebook

Twitter

LinkedIn

Business Practice

Business

Development

Legal

Policy

Practice

Regulatory

1rem

The Role of Biosimilars in Oncology

Global Perspective on the Effect of Biosimilars